Balchem (NASDAQ:BCPC) will announce its earnings results before the market opens on Thursday, February 28th. Analysts expect the company to announce earnings of $0.52 per share for the quarter.
Balchem stock opened at $84.29 on Wednesday. The stock has a market cap of $2.80 billion, a price-to-earnings ratio of 33.32 and a beta of 0.91. Balchem has a 52-week low of $73.16 and a 52-week high of $117.79. The company has a quick ratio of 2.33, a current ratio of 3.42 and a debt-to-equity ratio of 0.27.
A number of equities research analysts have issued reports on BCPC shares. HC Wainwright set a $101.00 price target on Balchem and gave the company a “buy” rating in a research note on Monday, December 10th. BidaskClub downgraded Balchem from a “sell” rating to a “strong sell” rating in a research note on Wednesday, November 28th. Zacks Investment Research downgraded Balchem from a “hold” rating to a “sell” rating in a research note on Tuesday, December 11th. Seaport Global Securities started coverage on Balchem in a research note on Thursday, February 21st. They set a “neutral” rating for the company. Finally, Pivotal Research upgraded Balchem from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $100.00 in a research note on Tuesday, November 6th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $105.50.
COPYRIGHT VIOLATION WARNING: “Balchem (BCPC) Set to Announce Quarterly Earnings on Thursday” was first published by Modern Readers and is the sole property of of Modern Readers. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.modernreaders.com/news/2019/02/27/balchem-bcpc-set-to-announce-quarterly-earnings-on-thursday.html.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.